John Marshall, MD; Edward Kim, MD; Paul Oberstein, MD; Allyson Ocean, MD; and Shubham Pant, MD, comment on variations of the FOLFIRINOX regimen in metastatic pancreatic cancer and their personal approaches to dosing and schedule.